Moderna, Inc. (0QF)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 202.50 |
|---|---|
| 52-week range | 19.37 – 222.10 |
| Return, 1 month / 3 months | +26.8% / +288.8% |
| Return, 1 year / 3 years | +774.7% / +168.4% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 110.0% |
| Worst drawdown (1 year) | -34.9% |
| Average daily value traded | 4.74M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Moderna is a biotechnology company based in Cambridge, Massachusetts, that develops medicines built on messenger RNA. Its products include vaccines and treatments for infectious diseases, and it also works on therapies in areas such as oncology and rare disease. The company serves public health authorities, governments and healthcare providers that buy its vaccines, and it carries out its own research and manufacturing.
Moderna, Inc. trades under the code 0QF on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Moderna, Inc. (0QF) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 202.50 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 65 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 774.7% and over the last three months it rose 288.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 184.2% | ||
| From 52-week high | -8.2% | ||
| Momentum | 100 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 288.8% | ||
| 6-month return | 331.8% | ||
| 12-month return, skipping the last month | 590.1% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 110.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.9% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 4.74M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −6.0% |
|---|---|
| 1 month | +26.8% |
| 3 months | +288.8% |
| 6 months | +331.8% |
| 1 year | +774.7% |
| 3 years | +168.4% |
| 5 years | −26.2% |
Signals
| 50-day / 200-day average | 147.95 / 71.26 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.00 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.